Patents by Inventor Christian Chabert

Christian Chabert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF GREEN COFFEE BASED COMPOSITIONS FOR IMPROVING INSULIN PROFILE
    Publication number: 20220175864
    Abstract: The present invention relates to a green coffee-based composition comprising hydrolysed chlorogenic acid for use in the treatment or prevention of a disorder linked to an increase in plasma postprandial insulin in a subject. The invention relates also to the non-therapeutic use of a composition comprising an esterase treated decaffeinated green coffee extract with an amount of 40-200 mg administered to a subject per day to decrease plasma postprandial insulin concentration. A further aspect of the invention is a process for forming green coffee based compositions.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 9, 2022
    Inventors: Lucas Actis Goretta, Jacklyn Ruilin Chen, Rachid Bel-Rhlid, Robin Willows, Marine Kraus, Christian Chabert
  • Method and kit for identifying and/or quantifying radiolabeled aminoglycoside binding molecules
    Patent number: 7157239
    Abstract: The present invention describes novel methods, assays and kits for identifying and/or quantifying Aminoglycoside Binding Molecules (ABMs), enzymes modifying such molecules, and compounds modulating the interaction between ABMs and either enzymes or aminoglycosides, by exploiting the scintillation proximity effect. The invention, which makes use of aminoglycoside-coated scintillating supports, can be adapted to high throughput screening formats.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: January 2, 2007
    Assignee: Applied Research Systems Ars Holding N.V.
    Inventors: Montserrat Camps, Christian Chabert, Dominique Perrin, Thierry Martin, Matthias Wymann, Christian Rommel
  • Novel scintillation proximity assays for aminoglycoside binding molecules (abms)
    Publication number: 20040219693
    Abstract: The present invention describes novel methods, assays and kits for identifying and/or quantifying Aminoglycoside Binding Molecules (ABMs), enzymes modifying such molecules, and compounds modulating the interaction between ABMs and either enzymes or aminoglycosides, by exploiting the scintillation proximity effect. The invention, which makes use of aminoglycoside-coated scintillating supports, can be adapted to high throughput screening formats.
    Type: Application
    Filed: June 30, 2004
    Publication date: November 4, 2004
    Inventors: Montserrat Camps, Christian Chabert, Dominique Perrin, Thierry Martin, Matthias Wymann, Christian Rommel